ascorbyl palmitate
Selected indexed studies
- Ascorbyl-6-palmitate is not ascorbic acid. (J Invest Dermatol, 2002) [PMID:12445183]
- Biological drug and drug delivery-mediated immunotherapy. (Acta Pharm Sin B, 2021) [PMID:33996408]
- Ascorbyl palmitate ameliorates inflammatory diseases by inhibition of NLRP3 inflammasome. (Int Immunopharmacol, 2024) [PMID:38522141]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ascorbyl-6-palmitate is not ascorbic acid. (2002) pubmed
- Biological drug and drug delivery-mediated immunotherapy. (2021) pubmed
- Ascorbyl palmitate ameliorates inflammatory diseases by inhibition of NLRP3 inflammasome. (2024) pubmed
- Liposomal Encapsulation of Ascorbyl Palmitate: Influence on Skin Performance. (2024) pubmed
- Ascorbyl palmitate nanofiber-reinforced hydrogels for drug delivery in soft issues. (2024) pubmed
- Enzymatic Synthesis of Ascorbyl Palmitate in a Rotating Bed Reactor. (2023) pubmed
- Ascorbyl palmitate/hyaluronan-modified poloxamer 407 nanoparticles for the topical delivery of fisetin to counteract UVB-induced skin photoaging: A novel anti-aging formulation. (2025) pubmed
- Encapsulation of ascorbyl palmitate in corn starch matrix by extrusion cooking: Release behavior and antioxidant activity. (2023) pubmed
- Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy. (2017) pubmed
- Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom. (2024) pubmed